| Similar Articles |
|---|
 |
Chemistry World
June 24, 2015
Patrick Walter |
Legal in theory Governments around the world are faced with the particularly tricky problem of what they should do about 'legal highs'.   |
Chemistry World
June 8, 2015
Maria Burke |
Warnings that proposed UK blanket ban on 'legal highs' casts net too wide Some legal experts and scientists are warning that a proposed blanket ban on so-called 'legal highs' won't tackle the problem and may well hold back research into areas such as neuroscience. |
Chemistry World
May 9, 2011
Sarah Houlton |
Ecstasy substitute poses major health risks Scientists at Anglia Ruskin University haves shown that one of the most common 'legal high' designer drugs, benzylpiperazine, is not only dangerous when it's taken - repeated consumption poses major health risks. |
Chemistry World
April 30, 2014
Emma Stoye |
New Zealand in legal highs U-turn Politicians in New Zealand have decided to ban designer drugs from sale in the country, reversing an earlier decision to approve low risk drugs while new laws are put in place. |
Chemistry World
May 29, 2015
Emma Stoye |
UK launches universal ban on legal highs New laws banning the sale and distribution of all legal highs -- or new psychoactive substances -- have been drafted by the UK government. |
Chemistry World
June 26, 2013
Emma Stoye |
UN report warns of global rise in legal highs The latest World Drug Report from the United Nations Office on Drugs and Crime says governments around the world are struggling to cope with a growing number of legal party drugs. |
Chemistry World
July 9, 2015
Maria Burke |
UK 'legal highs' bill under fire from scientific community Calls are growing from the scientific community for home secretary Theresa May to amend the psychoactive substances bill. |
Chemistry World
March 23, 2010 |
Comment: Can we halt the flow of new designer drugs? Could the dangers of 'legal high' mephedrone have been predicted? Of course they could, says John Mann |
Chemistry World
June 12, 2013
Maria Burke |
'Scientific censorship' hamstringing psychoactive drug research Legal controls on psychoactive drugs have hindered neuroscience research and the discovery of new treatments for brain disorders in 'one of the most scandalous examples of scientific censorship in modern times', claim researchers. |
Chemistry World
May 13, 2011
James Urquhart |
Synthetic cannabis drug test US researchers have developed a new urine test for detecting and quantifying some of the metabolites associated with synthetic cannabis. |
Chemistry World
February 17, 2015
Rebecca Trager |
Clinical trials high on list for medical marijuana community The drug's controlled status is continuing to slow efforts to investigate the myriad compounds in the plant. |
Chemistry World
April 24, 2014
Emma Stoye |
European parliament backs new rules on legal highs New regulations that will make it easier to ban legal highs have been backed by the European parliament. |
Chemistry World
June 12, 2015 |
Synthetic cannabinoid poisonings surge in US US poison control centres have experienced a 229% increase in the number of calls related to synthetic cannabinoid use in 2015 compared with last year. |
BusinessWeek
June 16, 2011
Ben Paynter |
The Big Business of Synthetic Highs Synthetic drugs that use legal compounds but mimic the highs of everything from marijuana to cocaine are proliferating among do-it-yourself pharma labs across the country. Bad trips - and fatal side effects - are increasing, too. |
Chemistry World
February 3, 2015 |
High hopes The multi-target, rebalancing properties of cannabinoids also explains why they show promise as drugs in such a wide variety of conditions. |
Chemistry World
May 15, 2009
Katrina Megget |
Tripping over red tape The UK may be moving a step closer to allowing the use of a cannabis-based drug to treat the symptoms of multiple sclerosis |
Chemistry World
August 25, 2015
Rebecca Trager |
Chemists wage war on designer drugs It is relatively simple to take a drug that has a known psychoactive effect and change one substituent group to make it into another drug that is not yet classified as illegal but provides the same or similar psychoactive high |
BusinessWeek
March 17, 2011
Justin Blum |
Cultivating Real Profits from Fake Weed Attempts by states to bar sales of substances that induce a marijuana-like high have been thwarted by nimble entrepreneurs. |
Chemistry World
January 11, 2012
Hayley Birch |
Drive towards detecting drugs at the roadside The UK government is setting up an advisory panel that will assess the feasibility of roadside testing for drug driving, similar to testing for drunk driving. |
Chemistry World
June 2008
Sarah Houlton |
Breaking the rules The author finds out about some chemical tricks that can give a new drug the best possible odds of success |
Chemistry World
June 3, 2015
Katrina Kramer |
Drugged: the science and culture behind psychotropic drugs Richard Miller, a pharmacology researcher at Northwestern University, US, and a medical humanities and bioethics professor, has written his first popular science book on the chemistry and culture of psychoactive compounds. |
Pharmaceutical Executive
February 1, 2006
Ron Feemster |
Gene Logic: Rescue Squad One or two late-stage clinical failures can land promising drug candidates on the shelf. Forever? Maybe not. Gene Logic tests Big Pharma's dead drugs for hundreds of different targets. |
Military & Aerospace Electronics
September 2007
Courtney E. Howard |
European Union launches Registration, Evaluation, Authorization, and Restriction of Chemicals regulation The EU's recently enacted REACH law makes industry manufacturers, importers, and systems developers responsible for the identification, management, and substitution of chemical substances. |
Chemistry World
April 25, 2013
Andreas Barth |
Chemical bibliometrics Counting compounds instead of publications and citations opens new perspectives for data-based scientific discovery and it can complement and stimulate both experimental and theoretical research. |
Chemistry World
August 2008 |
Column: In the pipeline Problems develop when there are too few workhorse reactions, which may well generate compounds that are too similar to each other. Are we at that stage now? |
The Motley Fool
August 6, 2007
Brian Orelli |
Cheap Drugs on the Farm The House approves a prescription-drug import provision. Investors should keep an eye on the status of the bill, because laws that hurt the drugmakers' bottom lines will hurt their stock prices as well. |
Salon.com
August 4, 2000
Gary Kamiya |
Writing high In "Writing on Drugs," Sadie Plant embarks on a stimulating trip into literature's strangest, smokiest den. |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
The Motley Fool
January 8, 2008
Brian Orelli |
Brits May Bludgeon Drug Companies The U.K.'s National Health Service delivers a shock to drugmakers; it is considering a 10% drop in the rate that it pays for drugs, to help it reach its goal of a 3% reduction in the nation's overall health-care bill. |
Chemistry World
August 2009
Derek Lowe |
Column: In the pipeline The author considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder |
Chemistry World
April 2011 |
Column: In the Pipeline If you look over the whole pharmacopeia, you'll see there are a lot of compounds that got their start as natural products. |
The Motley Fool
December 12, 2007
Brian Lawler |
Patent Bill Is No Panacea A new bill that was meant to strengthen the patent and other intellectual-property rights of drugmakers doesn't do enough to encourage pharma innovation. |
Fast Company
February 2004
Bill Breen |
Dr. Dope's Connection David Watson, the CEO of the Dutch pharmaceutical R&D company Hortapharm, has assembled what is arguably the world's most comprehensive cannabis-seed library. |
